Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Integer Holdings ( (ITGR) ) is now available.
On October 24, 2025, Integer Holdings Corporation announced the completion of its planned leadership transition with Payman Khales assuming the roles of President and CEO, succeeding Joseph Dziedzic. Mr. Khales, who joined Integer in 2018, has been instrumental in driving growth and improving service levels in his previous roles, and his appointment is expected to continue advancing the company’s strategic goals and strengthen its position as a strategic partner in the medical device industry.
The most recent analyst rating on (ITGR) stock is a Buy with a $77.00 price target. To see the full list of analyst forecasts on Integer Holdings stock, see the ITGR Stock Forecast page.
Spark’s Take on ITGR Stock
According to Spark, TipRanks’ AI Analyst, ITGR is a Neutral.
Integer Holdings’ overall stock score is driven by strong financial performance and a positive earnings call, highlighting robust growth and operational efficiency. However, technical analysis indicates bearish momentum, and the high P/E ratio suggests potential overvaluation. The absence of a dividend yield further impacts the valuation score.
To see Spark’s full report on ITGR stock, click here.
More about Integer Holdings
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) globally, focusing on cardiac rhythm management, neuromodulation, and cardio and vascular markets. The company is a strategic partner to medical device companies and OEMs, committed to providing innovative, high-quality products and solutions to enhance patient lives worldwide.
Average Trading Volume: 610,218
Technical Sentiment Signal: Buy
Current Market Cap: $3.82B
Find detailed analytics on ITGR stock on TipRanks’ Stock Analysis page.